LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,113
تعداد مقالات10,208
تعداد مشاهده مقاله40,771,459
تعداد دریافت فایل اصل مقاله8,800,563
Semati, Ali, Zare, Marjan, Mirahmadizadeh, Alireza, Hemmati, Abdulrasool, Ebrahimi, Mostafa. (1401). Epidemiological Study of Infection and Death Due to COVID-19 in Fars Province, Iran, From February to September 2020. سامانه مدیریت نشریات علمی, 47(3), 219-226. doi: 10.30476/ijms.2021.90768.2174
Ali Semati; Marjan Zare; Alireza Mirahmadizadeh; Abdulrasool Hemmati; Mostafa Ebrahimi. "Epidemiological Study of Infection and Death Due to COVID-19 in Fars Province, Iran, From February to September 2020". سامانه مدیریت نشریات علمی, 47, 3, 1401, 219-226. doi: 10.30476/ijms.2021.90768.2174
Semati, Ali, Zare, Marjan, Mirahmadizadeh, Alireza, Hemmati, Abdulrasool, Ebrahimi, Mostafa. (1401). 'Epidemiological Study of Infection and Death Due to COVID-19 in Fars Province, Iran, From February to September 2020', سامانه مدیریت نشریات علمی, 47(3), pp. 219-226. doi: 10.30476/ijms.2021.90768.2174
Semati, Ali, Zare, Marjan, Mirahmadizadeh, Alireza, Hemmati, Abdulrasool, Ebrahimi, Mostafa. Epidemiological Study of Infection and Death Due to COVID-19 in Fars Province, Iran, From February to September 2020. سامانه مدیریت نشریات علمی, 1401; 47(3): 219-226. doi: 10.30476/ijms.2021.90768.2174

Epidemiological Study of Infection and Death Due to COVID-19 in Fars Province, Iran, From February to September 2020

Iranian Journal of Medical Sciences
مقاله 5، دوره 47، شماره 3، مرداد 2022، صفحه 219-226    اصل مقاله (759.15 K)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2021.90768.2174
نویسندگان
Ali Semati1؛ Marjan Zare* 1؛ Alireza Mirahmadizadeh1؛ Abdulrasool Hemmati1؛ Mostafa Ebrahimi2
1Non-Communicable Disease Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2Communicable Disease Control Center, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has entered our lives with the fear of outbreak, death, and recurrence. Our objective in this study is to evaluate the epidemiological features of Coronavirus Disease 2019 (COVID-19) infection and death in Fars province, Iran.
Methods: A cross-sectional study was conducted from February 18th to September 30th, 2020, where age, history of underlying diseases, sex, community-wide quarantine, nationality, close contact, pregnancy, medical staff job, traveling , and residency were compared between alive and deceased groups. Data were analyzed using IBM SPSS software, version 22.0, and the significance level was set at 0.05.
Results: Regarding 57958 new cases of COVID-19, the basic reproduction number (R0) was estimated as 2.8, requiring a minimum of 65% immunization to reach herd immunity. Moreover, an R0=0.36 was required to reach the endemic state in the region. The incidence, mortality, fatality, and recurrence rates of COVID-19 were estimated as 1347.9 per 100,000 dwellers, 209.5 per 1000,000 dwellers, 1.6 %, and 3.1 per 100,000 dwellers, respectively. Age, history of underlying diseases, urban residency, and the male sex were significantly higher in the deceased group (OR=1.09, 5.48, 1.24, and 1.32; All Ps<0.001, <0.001, 0.005, and <0.001, respectively). In addition, the recurrence rate among positive cases was estimated as 0.23% with a median±inter-quartile range equal to 84±46.25 days. Community-wide quarantine was shown to be a protective factor for death due to COVID-19 (OR=0.58, P=0.005).
Conclusion: Community-wide quarantine blocks the transmission of COVID-19 effectively. COVID-19 enjoys no solid immunity. History of underlying diseases, the male sex, urban residency, and age were among the most significant causes of death due to COVID-19. Further investigations are recommended on the genetic structure of SARS-CoV-2, treatments, and vaccination.
کلیدواژه‌ها
COVID-19؛ SARS-CoV-2؛ Infections؛ Death؛ Epidemiologic studies
سایر فایل های مرتبط با مقاله
مراجع
  1. Yang P, Wang X, Liu P, Wei C, He B, Zheng J, et al. Clinical characteristics and risk assessment of newborns born to mothers with COVID-19. J Clin Virol. 2020;127:104356. doi: 10.1016/j.jcv.2020.104356. PubMed PMID: 32302955; PubMed Central PMCID: PMCPMC7194834.
  2. Xie M, Chen Q. Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis. 2020;94:119-24. doi: 10.1016/j.ijid.2020.03.071. PubMed PMID: 32247050; PubMed Central PMCID: PMCPMC7118633.
  3. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362. doi: 10.1016/j.jcv.2020.104362. PubMed PMID: 32305883; PubMed Central PMCID: PMCPMC7195278.
  4. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924. doi: 10.1016/j.ijantimicag.2020.105924. PubMed PMID: 32081636; PubMed Central PMCID: PMCPMC7127800.
  5. Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Sci Total Environ. 2020;730:138996. doi: 10.1016/j.scitotenv.2020.138996. PubMed PMID: 32371230; PubMed Central PMCID: PMCPMC7190497.
  6. Al-Qahtani AA. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Emergence, history, basic and clinical aspects. Saudi J Biol Sci. 2020;27:2531-8. doi: 10.1016/j.sjbs.2020.04.033. PubMed PMID: 32336927; PubMed Central PMCID: PMCPMC7179492.
  7. Kang S, Peng W, Zhu Y, Lu S, Zhou M, Lin W, et al. Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment. Int J Antimicrob Agents. 2020;55:105950. doi: 10.1016/j.ijantimicag.2020.105950. PubMed PMID: 32234465; PubMed Central PMCID: PMCPMC7118423.
  8. Singh A, Shaikh A, Singh R, Singh AK. COVID-19: From bench to bed side. Diabetes Metab Syndr. 2020;14:277-81. doi: 10.1016/j.dsx.2020.04.011. PubMed PMID: 32283498; PubMed Central PMCID: PMCPMC7194797.
  9. Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020;55:105951. doi: 10.1016/j.ijantimicag.2020.105951. PubMed PMID: 32234466; PubMed Central PMCID: PMCPMC7139247.
  10. Tu H, Tu S, Gao S, Shao A, Sheng J. Current epidemiological and clinical features of COVID-19; a global perspective from China. J Infect. 2020;81:1-9. doi: 10.1016/j.jinf.2020.04.011. PubMed PMID: 32315723; PubMed Central PMCID: PMCPMC7166041.
  11. Law S, Leung AW, Xu C. Severe acute respiratory syndrome (SARS) and coronavirus disease-2019 (COVID-19): From causes to preventions in Hong Kong. Int J Infect Dis. 2020;94:156-63. doi: 10.1016/j.ijid.2020.03.059. PubMed PMID: 32251790; PubMed Central PMCID: PMCPMC7195109.
  12. Mirmohammadkhani M, Paknazar F, Rashidy-Pour A. Evaluation of the epidemiological pattern of COVID-19 applying basic reproduction number: an educational review article. Koomesh. 2020;22:373-9. doi: 10.29252/koomesh.22.3.373.
  13. Aghaali M, Kolifarhood G, Nikbakht R, Saadati HM, Hashemi Nazari SS. Estimation of the serial interval and basic reproduction number of COVID-19 in Qom, Iran, and three other countries: A data-driven analysis in the early phase of the outbreak. Transbound Emerg Dis. 2020;67:2860-8. doi: 10.1111/tbed.13656. PubMed PMID: 32473049; PubMed Central PMCID: PMCPMC7300937.
  14. Shahriarirad R, Khodamoradi Z, Erfani A, Hosseinpour H, Ranjbar K, Emami Y, et al. Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran. BMC Infect Dis. 2020;20:427. doi: 10.1186/s12879-020-05128-x. PubMed PMID: 32552751; PubMed Central PMCID: PMCPMC7301075.
  15. Nikpouraghdam M, Jalali Farahani A, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J Clin Virol. 2020;127:104378. doi: 10.1016/j.jcv.2020.104378. PubMed PMID: 32353762; PubMed Central PMCID: PMCPMC7172806.
  16. McHugh ML. The odds ratio: calculation, usage, and interpretation. Biochemia medica. 2009;19:120-6. doi: 10.11613/BM.2009.011.
  17. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91-8. doi: 10.1016/j.jare.2020.03.005. PubMed PMID: 32257431; PubMed Central PMCID: PMCPMC7113610.
  18. Abd El-Aziz TM, Stockand JD. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status. Infect Genet Evol. 2020;83:104327. doi: 10.1016/j.meegid.2020.104327. PubMed PMID: 32320825; PubMed Central PMCID: PMCPMC7166307.
  19. Pan A, Liu L, Wang C, Guo H, Hao X, Wang Q, et al. Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China. JAMA. 2020;323:1915-23. doi: 10.1001/jama.2020.6130. PubMed PMID: 32275295; PubMed Central PMCID: PMCPMC7149375.
  20. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 2020;13:667-73. doi: 10.1016/j.jiph.2020.03.019. PubMed PMID: 32340833; PubMed Central PMCID: PMCPMC7142680.
  21. Perez-Lopez FR, Tajada M, Saviron-Cornudella R, Sanchez-Prieto M, Chedraui P, Teran E. Coronavirus disease 2019 and gender-related mortality in European countries: A meta-analysis. Maturitas. 2020;141:59-62. doi: 10.1016/j.maturitas.2020.06.017. PubMed PMID: 33036704; PubMed Central PMCID: PMCPMC7309755.
  22. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81:e16-e25. doi: 10.1016/j.jinf.2020.04.021. PubMed PMID: 32335169; PubMed Central PMCID: PMCPMC7177098.
  23. Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. Severe COVID-19 during Pregnancy and Possible Vertical Transmission. Am J Perinatol. 2020;37:861-5. doi: 10.1055/s-0040-1710050. PubMed PMID: 32305046; PubMed Central PMCID: PMCPMC7356080.
  24. Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020;222:521-31. doi: 10.1016/j.ajog.2020.03.021. PubMed PMID: 32217113; PubMed Central PMCID: PMCPMC7270569.
  25. Kasraeian M, Zare M, Vafaei H, Asadi N, Faraji A, Bazrafshan K, et al. COVID-19 pneumonia and pregnancy; a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2020:1-8. doi: 10.1080/14767058.2020.1763952. PubMed PMID: 32429786.
  26. Schwartz DA. An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Arch Pathol Lab Med. 2020;144:799-805. doi: 10.5858/arpa.2020-0901-SA. PubMed PMID: 32180426.
  27. Takemoto MLS, Menezes MO, Andreucci CB, Knobel R, Sousa LAR, Katz L, et al. Maternal mortality and COVID-19. J Matern Fetal Neonatal Med. 2020:1-7. doi: 10.1080/14767058.2020.1786056. PubMed PMID: 32674646.
  28. Bonifacio LP, Pereira APS, Araujo D, Balbao V, Fonseca B, Passos ADC, et al. Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil. Rev Soc Bras Med Trop. 2020;53:e20200619. doi: 10.1590/0037-8682-0619-2020. PubMed PMID: 32965458; PubMed Central PMCID: PMCPMC7508196.
  29. Chen D, Xu W, Lei Z, Huang Z, Liu J, Gao Z, et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report. Int J Infect Dis. 2020;93:297-9. doi: 10.1016/j.ijid.2020.03.003. PubMed PMID: 32147538; PubMed Central PMCID: PMCPMC7129213.
  30. Fernandes Valente Takeda C, Moura de Almeida M, Goncalves de Aguiar Gomes R, Cisne Souza T, Alves de Lima Mota M, Pamplona de Goes Cavalcanti L, et al. Case Report: Recurrent Clinical Symptoms of COVID-19 in Healthcare Professionals: A Series of Cases from Brazil. Am J Trop Med Hyg. 2020;103:1993-6. doi: 10.4269/ajtmh.20-0893. PubMed PMID: 32888288; PubMed Central PMCID: PMCPMC7646791.
  31. Xiao AT, Tong YX, Zhang S. False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence. J Med Virol. 2020;92:1755-6. doi: 10.1002/jmv.25855. PubMed PMID: 32270882; PubMed Central PMCID: PMCPMC7262304.
  32. Zhou L, Liu K, Liu HG. [Cause analysis and treatment strategies of “recurrence” with novel coronavirus pneumonia (COVID-19) patients after discharge from hospital]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:281-4. doi: 10.3760/cma.j.cn112147-20200229-00219. PubMed PMID: 32118391.
  33. Sjodin H, Wilder-Smith A, Osman S, Farooq Z, Rocklov J. Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020. Euro Surveill. 2020;25. doi: 10.2807/1560-7917.ES.2020.25.13.2000280. PubMed PMID: 32265005; PubMed Central PMCID: PMCPMC7140595.
  34. Aleta A, Martin-Corral D, Pastore YPA, Ajelli M, Litvinova M, Chinazzi M, et al. Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19. Nat Hum Behav. 2020;4:964-71. doi: 10.1038/s41562-020-0931-9. PubMed PMID: 32759985; PubMed Central PMCID: PMCPMC7641501.
  35. Parmet WE, Sinha MS. Covid-19 - The Law and Limits of Quarantine. N Engl J Med. 2020;382:e28. doi: 10.1056/NEJMp2004211. PubMed PMID: 32187460.
  36. Muscogiuri G, Barrea L, Savastano S, Colao A. Nutritional recommendations for CoVID-19 quarantine. Eur J Clin Nutr. 2020;74:850-1. doi: 10.1038/s41430-020-0635-2. PubMed PMID: 32286533; PubMed Central PMCID: PMCPMC7155155.
  37. Mazza M, Marano G, Lai C, Janiri L, Sani G. Danger in danger: Interpersonal violence during COVID-19 quarantine. Psychiatry Res. 2020;289:113046. doi: 10.1016/j.psychres.2020.113046. PubMed PMID: 32387794; PubMed Central PMCID: PMCPMC7190494.
آمار
تعداد مشاهده مقاله: 4,862
تعداد دریافت فایل اصل مقاله: 2,684


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب